N.E.W. Advisory Services LLC Cytosorbents Corp Transaction History
N.E.W. Advisory Services LLC
- $1.25 Billion
- Q1 2025
A detailed history of N.E.W. Advisory Services LLC transactions in Cytosorbents Corp stock. As of the latest transaction made, N.E.W. Advisory Services LLC holds 2,720 shares of CTSO stock, worth $2,339. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,720Holding current value
$2,339% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CTSO
# of Institutions
56Shares Held
17.2MCall Options Held
8.1KPut Options Held
6.9K-
Avenir Corp Washington, DC5.04MShares$4.34 Million0.55% of portfolio
-
Skylands Capital, LLC3MShares$2.58 Million0.48% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$1.68 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY1.68MShares$1.44 Million0.0% of portfolio
-
Cm Management, LLC954KShares$820,5051.04% of portfolio
About Cytosorbents Corp
- Ticker CTSO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 43,577,400
- Market Cap $37.5M
- Description
- Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...